Cell-type-specific alternative polyadenylation as a therapeutic biomarker in lung cancer progression

Kang Li; Min Qiang; Yungang Xu

doi:10.1016/j.omtn.2023.102030

Cell-type-specific alternative polyadenylation as a therapeutic biomarker in lung cancer progression

Kang Li
, Min Qiang
, Yungang Xu

Health Science Center

Xi'an Jiaotong University

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Article number	102030
Journal	Molecular Therapy Nucleic Acids
Volume	34
DOIs	https://doi.org/10.1016/j.omtn.2023.102030
State	Published - 12 Dec 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.omtn.2023.102030

Cite this

@article{1ee8473a49e544b69e0674c9d4ba5e01,

title = "Cell-type-specific alternative polyadenylation as a therapeutic biomarker in lung cancer progression",

author = "Kang Li and Min Qiang and Yungang Xu",

year = "2023",

month = dec,

day = "12",

doi = "10.1016/j.omtn.2023.102030",

language = "英语",

volume = "34",

journal = "Molecular Therapy Nucleic Acids",

issn = "2162-2531",

publisher = "Cell Press",

}

TY - JOUR

T1 - Cell-type-specific alternative polyadenylation as a therapeutic biomarker in lung cancer progression

AU - Li, Kang

AU - Qiang, Min

AU - Xu, Yungang

PY - 2023/12/12

Y1 - 2023/12/12

UR - https://www.scopus.com/pages/publications/85171540380

U2 - 10.1016/j.omtn.2023.102030

DO - 10.1016/j.omtn.2023.102030

M3 - 评论/辩论

AN - SCOPUS:85171540380

SN - 2162-2531

VL - 34

JO - Molecular Therapy Nucleic Acids

JF - Molecular Therapy Nucleic Acids

M1 - 102030

ER -

Cell-type-specific alternative polyadenylation as a therapeutic biomarker in lung cancer progression

UN SDGs

Access to Document

Other files and links

Cite this